#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Sarcoma Chorioretinitis Non-renal cell carcinoma of kidney Barth syndrome Transferrin decreased Emphysema Metabolic disorder Gastroenteropancreatic neuroendocrine tumour disease Leukoencephalopathy Inclusion body myositis Partial lipodystrophy Vitamin B12 deficiency Ovarian epithelial cancer Alport's syndrome Hypersensitivity pneumonitis More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Trials in Disease Hairy cell leukaemia recurrent – Life with Disease Fragile X syndrome – Treatment Paroxysmal nocturnal haemoglobinuria – Treatment KBG syndrome – Life with Disease Leiomyosarcoma – Diagnostics Pelizaeus-Merzbacher disease – Diagnostics Chronic granulomatous disease – Treatment Paraneoplastic neurological syndrome – Treatment Mastocytosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Valiltramiprosate ARTICAINE HYDROCHLORIDE COBALAMIN Fluorescein Sodium Mbs2320 Fosinopril Sodium Pentoxifylline Ht-29-B Flutafuranol (18F) Tremelimumab Ferric Carboxymaltose Rbd4059 Trametinib Dimethyl Sulfoxide Alemtuzumab OSIMERTINIB MESYLATE Mosaic Hbcoreag M-(18F)-Fluorobenzylguanidine XYLOMETAZOLINE HYDROCHLORIDE Cabotegravir Iph6501 More therapies…

    Learn about Your Condition

    Embolism Retroperitoneal cancer Acute lymphocytic leukaemia Cataract Herpes simplex reactivation Athetosis Nodal osteoarthritis Rectal neoplasm Apheresis Langerhans cell sarcoma Blood disorder Sinus rhythm Venous thrombosis Extraskeletal ossification Skin cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Brain Imaging with [18F]PI-2620 for Progressive Supranuclear Palsy Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Progressive supranuclear palsy
    Investigated Drugs:
    • Izaflortaucipir (18F)
    Spain

  • Study on the Safety and Effects of Plasma Transfusion from Exercise-Trained Donors in Patients with Early Alzheimer’s Disease Using Human Plasma Protein and Saline

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Human Plasma Protein
    • Saline
    Norway

  • Study on the Safety and Tolerability of BIIB115 for Children with Spinal Muscular Atrophy Previously Treated with Gene Therapy

    Not recruiting

    1 1
    Investigated Diseases:
    • Spinal muscular atrophy
    Investigated Drugs:
    • BIIB115
    Belgium France Germany Italy The Netherlands Poland

  • Study on Detecting Nitrous Oxide in Healthy Volunteers Using Nitrous Oxide and Oxygen to Help Victims of Nitrous Oxide Intoxication

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Nitrous Oxide
    • Oxygen
    • Paracetamol
    Denmark

  • Study on the Effects of Tetrodotoxin for Pain Relief in Healthy Volunteers

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pain
    Investigated Drugs:
    • TETRODOTOXIN
    The Netherlands

  • Study on How Minzasolmin is Absorbed in the Body and its Safety in Healthy Adults

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Minzasolmin
    Germany
Previous Page
1 … 87 88 89 90 91 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!